ocular gene therapy rapidly become reality novel approx clinic trial approve ass novel agent viral infect herpes great caps her simplex virus hsv caps serious complex may lead blind recur disease like cornea transplant therefore might ideal therapeutic solute paper focus current stat research include use noir vector rout delivery gene new technique key strategy where correct inherit disease init goal field discus transfer express replace silent clip previous report literature screen emphasis candid target commonly adopt discus rel advantage protect use antivirus drug common longterm sign inflamed neovascular success provide into physiology pharmacist solute 